div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: · · 2017-01-21Slide courtes of Jedd WolchoWTaha Me Gastrointestind Cancers - MD Learning Objectives immune check point inhibitors still under evaluation src=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: · · 2017-01-21Slide courtes of Jedd WolchoWTaha Me Gastrointestind Cancers - MD Learning Objectives immune check point inhibitors still under evaluation src=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: · · 2017-01-21Slide courtes of Jedd WolchoWTaha Me Gastrointestind Cancers - MD Learning Objectives immune check point inhibitors still under evaluation src=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader040fdocumentsusreader040viewer20220307175b01f34d7f8b9ab9598d1a81html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: · · 2017-01-21Slide courtes of Jedd WolchoWTaha Me Gastrointestind Cancers - MD Learning Objectives immune check point inhibitors still under evaluation...